Clinical Trial: Systemic Antifungal Plus Q-Switched Nd:YAG Laser for Onychomycosis

U.S., Oct. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07869706) titled 'Systemic Antifungal Plus Q-Switched Nd:YAG Laser for Onychomycosis' on Oct. 06.

Brief Summary: This randomized controlled trial aims to compare the efficacy and safety of systemic terbinafine combined with Q-switched Nd:YAG laser versus systemic terbinafine alone in the treatment of onychomycosis.

Study Start Date: Oct. 10

Study Type: INTERVENTIONAL

Condition: Onychomycosis

Intervention: DRUG: Terbinafine

Oral terbinafine 250 mg once daily for 6 weeks (fingernails) or 12 weeks (toenails).

DEVICE: Q-switched Nd:YAG laser

Q-switched Nd:YAG laser (1064 nm) applied to the affected nail plate, 4 passes per session, every 2 weeks...